Product monographs published by Canadian manufacturers are now available through RxVigilance. To access these documents, use the Search box on the main screen, or go to the Useful Links section in our product monographs.
To meet Health Canada?s regulations regarding measures that must be taken when selling opioid medications, RxVigilance places at your disposal a patient information handout.This document, developed by Health Canada, provides information about the safe use of opioids and the risks associated with their use.
We have created a comparative table for oral antiplatelets. Included in the table are figures summarizing the Canadian guidelines for antiplatelet therapy in patients undergoing percutaneous coronary intervention, as well as a summary of the Canadian Stroke Best Practice Recommendations from the Heart and Stroke Foundation.
Good news! Vigilance Santé has now integrated the new Canadian Clinical Drug Data Set (CCDD) codes developed by Canada Health Infoway into its databases. Correspondences have thus been established between the TM and NTP codes from the CCDD and the DINs, GENcodes and generx codes from Vigilance. These codes can now be sent to the analysis engine in an input element that accepts a GEN-code or a generx code; simply add the suffix "/ ntp or / tm" after the code.
Did you know that you can do an overview of the various RxVigilance modules? By using the "Help" shortcut at the top of your screen, you can access tutorials aimed at helping you familiarize yourself with the content available in each of the sections.